<DOC>
	<DOCNO>NCT01936350</DOCNO>
	<brief_summary>Twenty-four patient know heart failure recruit . They undergo cardiac magnetic resonance ventricular analysis first exam randomize placebo Sildenafil . After one hour drug intake undergo another cardiac magnetic resonance evaluate drug impact right leave ventricular function .</brief_summary>
	<brief_title>Sildenafil Impact Ventricular Function Patients With Heart Failure</brief_title>
	<detailed_description>Twenty-four patient know heart failure recruit . They undergo cardiac magnetic resonance ventricular analysis first exam randomize placebo sildenafil . After one hour drug intake undergo another cardiac magnetic resonance evaluate drug impact right leave ventricular function . The first second exam perform staff . All patient evaluate two , three four chamber view . Left right ventricle quantification analysis perform Argus software .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Sildenafil Citrate</mesh_term>
	<criteria>Patients heart failure stable clinical condition compatible New York Heart Association functional class I III . Eligibility criteria consent participate study receive detailed information procedure , possible clinical benefit , risk . patient new diagnosed lesion procedure , eg pulmonary mass important claustrophobia , low blood pressure ( systolic blood pressure &lt; 90 mmHg diastolic blood pressure &lt; 60 mmHg ) nitrate nebivolol use last 48 hour , metallic non MRI compatible implantable device .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Heart failure</keyword>
</DOC>